资讯
融资
2 小时之前
TRYNGOLZA™ (olezarsen) approved in the EU for severe hypertriglyceridemia (sHTG)
上市批准引进/卖出
2 小时之前
并购引进/卖出
2 小时之前
Acadia Pharmaceuticals Presents Additional Phase 2 RADIANT Study Results Evaluating Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis at the 2026 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
临床结果
2026-11-17
FREHEMGO® (denecimig) approved in the EU for haemophilia A, with a choice of monthly, every-two-weeks or weekly dosing
上市批准临床结果
Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
临床结果上市批准孤儿药
2026-11-17
FDA OKs third renal indication for Roche's Gazyva, this time primary membranous nephropathy
临床结果上市批准优先审批突破性疗法
2026-11-17
AstraZeneca's next-gen C5 inhibitor Klygefa approved in US, EU for gMG
临床结果上市批准
2026-11-14
New Drug Application Submission Completed for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
申请上市上市批准临床结果
2026-11-14
LEO Pharma announces NMPA-approval of Anzupgo® (delgocitinib) cream for patients with moderate to severe chronic hand eczema (CHE) in China
临床结果上市批准引进/卖出
提出任何生物医药研究问题
让每一步生物医药决策都精准制胜
基于十亿级生物数据与全球情报的精准 AI,赋能早期药物发现
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即接入生物医药数据包
智慧芽新药库数据也通过智慧芽开放平台,以MCP或API服务形式对外开放。立即使用我们的MCP服务定制您的LLM智能体。